These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8920064)

  • 1. The changing marketplace: informed choices; safe action.
    Rubin MS
    J Am Coll Dent; 1996; 63(1):14-8. PubMed ID: 8920064
    [No Abstract]   [Full Text] [Related]  

  • 2. Competition and antitrust enforcement in the changing pharmaceutical marketplace.
    Whitener MD
    Food Drug Law J; 1995; 50(2):301-7. PubMed ID: 10342998
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct reimbursement and the conspiracy of silence.
    Plunkett LR
    N Y State Dent J; 1997 Oct; 63(8):6-9. PubMed ID: 9375505
    [No Abstract]   [Full Text] [Related]  

  • 4. DSSNY, managed care and antitrust laws. A marriage of necessity.
    Plunkett LR
    N Y State Dent J; 1996 May; 62(5):8-11. PubMed ID: 8692465
    [No Abstract]   [Full Text] [Related]  

  • 5. The fraud and abuse statute in an evolving health care marketplace: life in the health care speakeasy.
    Blumstein JF
    Am J Law Med; 1996; 22(2-3):205-31. PubMed ID: 8862242
    [No Abstract]   [Full Text] [Related]  

  • 6. Physician negotiations with managed care plans: a primer of antitrust pitfalls.
    Ronai SE; Hudner HK
    Conn Med; 1992 Oct; 56(10):571-6. PubMed ID: 1458883
    [No Abstract]   [Full Text] [Related]  

  • 7. Avoid the antitrust trap: providers must study the law before they partner.
    Litwak P
    Behav Healthc Tomorrow; 1999 Aug; 8(4):19-23. PubMed ID: 10557691
    [No Abstract]   [Full Text] [Related]  

  • 8. Managed competition, integrated delivery systems and antitrust.
    Greaney TL
    Cornell Law Rev; 1994 Sep; 79(6):1507-45. PubMed ID: 10141442
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitrust reform: equality at the bargaining table.
    Palmisano DJ
    J La State Med Soc; 1994 Oct; 146(10):427-8. PubMed ID: 7798774
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitrust warning. Court: dental association's advertising limits restrict trade.
    Japsen B
    Mod Healthc; 1997 Nov; 27(44):16. PubMed ID: 10174142
    [No Abstract]   [Full Text] [Related]  

  • 11. 1995 Le Tourneau Award. An antitrust analysis of physician specialty networks under changing market conditions.
    Woodhall AL
    J Leg Med; 1996 Sep; 17(3):383-425. PubMed ID: 9111771
    [No Abstract]   [Full Text] [Related]  

  • 12. Market power, collusion, and exclusion in health care antitrust enforcement.
    Spears JM
    J Med Assoc Ga; 1992 Sep; 81(9):499-507. PubMed ID: 1402429
    [No Abstract]   [Full Text] [Related]  

  • 13. Strength in numbers or antitrust trouble?
    Bianculli JL
    Contemp Longterm Care; 1997 May; 20(5):60-1. PubMed ID: 10167546
    [No Abstract]   [Full Text] [Related]  

  • 14. ISN legislation changing health care delivery. Physicians should prepare to compete in new marketplace.
    LaFond MA
    Minn Med; 1993 Jul; 76(7):27-30. PubMed ID: 8377735
    [No Abstract]   [Full Text] [Related]  

  • 15. U.S. Supreme Court and Federal Trade Commission determine medicine is not a profession. Decision affects patient care.
    Gale AH
    Mo Med; 1997 Jul; 94(7):319-20. PubMed ID: 9223900
    [No Abstract]   [Full Text] [Related]  

  • 16. Networks can avoid antitrust scrutiny.
    Waxman JM
    Provider; 1997 Feb; 23(2):42-5. PubMed ID: 10167120
    [No Abstract]   [Full Text] [Related]  

  • 17. Old wine in new bottles: the increased antitrust risk of hospital diversification.
    Kopit WG; McCann RW
    Spec Law Dig Health Care Law; 1993 Jun; (172):9-42. PubMed ID: 10126840
    [No Abstract]   [Full Text] [Related]  

  • 18. How to kill managed care.
    Lowe GH
    Ear Nose Throat J; 1998 Aug; 77(8):592-4, 596-600, 602 passim. PubMed ID: 9745176
    [No Abstract]   [Full Text] [Related]  

  • 19. Sword or shield? An overview and competitive analysis of the marketing of "authorized generics".
    Zain S
    Food Drug Law J; 2007; 62(4):739-77. PubMed ID: 18557229
    [No Abstract]   [Full Text] [Related]  

  • 20. Risky business: proposed reform of the antitrust laws as applied to health care provider networks.
    Marjancik N
    Am J Law Med; 1998; 24(1):59-87. PubMed ID: 9607104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.